136 related articles for article (PubMed ID: 38487742)
1. Transplant and non-transplant HCC patients at a single institution.
Carr BI; Bag H; Ince V; Isik B; Baskiran A; Yilmaz S
Hepatol Forum; 2024; 5(2):77-86. PubMed ID: 38487742
[TBL] [Abstract][Full Text] [Related]
2. Discordance among aggressiveness characteristics of hepatocellular carcinoma: Portal vein thrombosis and multifocality, related to tumor size, but not to serum alpha-fetoprotein level.
Carr BI; Guerra V; Ince V; Isik B; Yilmaz S
Liver Res; 2023 Sep; 7(3):256-262. PubMed ID: 37854945
[TBL] [Abstract][Full Text] [Related]
3. Macroscopic Portal Vein Thrombosis in HCC Patients.
Akkiz H; Carr BI; Kuran S; Karaoğullarından Ü; Üsküdar O; Tokmak S; Arslan B; Doran F; Balli HT; Ülkü A; Akçam TA; Bahçeci Hİ; Polat KY; Örmeci N; Şimşek H; Sonsuz A; Demir A; Altıntaş E; Demir M; Yalçın K; Ekinci N; Harmancı Özakyol A; Yücesoy M; Uygun A; Guerra V; Delik A; Tokat Y; Yilmaz S; Bektaş A; Kılıç M
Can J Gastroenterol Hepatol; 2018; 2018():3120185. PubMed ID: 30009156
[TBL] [Abstract][Full Text] [Related]
4. Relationships Between Indices of Tumor Aggressiveness in Hepatocellular Carcinoma.
Carr BI; Guerra V; Donghia R; Yilmaz S
J Gastrointest Cancer; 2021 Dec; 52(4):1340-1349. PubMed ID: 34611834
[TBL] [Abstract][Full Text] [Related]
5. Trends in Tumor Indices in Relation to Increased Hepatocellular Carcinoma Size: Evidence for Tumor Evolution as a Function of Growth.
Carr BI; Guerra V; Donghia R; Yilmaz S
J Gastrointest Cancer; 2020 Dec; 51(4):1215-1219. PubMed ID: 33006073
[TBL] [Abstract][Full Text] [Related]
6. Liver transplant for large hepatocellular carcinoma in Malatya: The role of gamma glutamyl transferase and alpha-fetoprotein, a retrospective cohort study.
Ince V; Carr BI; Bag HG; Ersan V; Usta S; Koc C; Gonultas F; Sarici BK; Karakas S; Kutluturk K; Baskiran A; Yilmaz S
World J Gastrointest Surg; 2020 Dec; 12(12):520-533. PubMed ID: 33437403
[TBL] [Abstract][Full Text] [Related]
7. Correlation of Clinicopathological Profile, Prognostic Factors, and Survival Outcomes with Baseline Alfa-Fetoprotein Levels in Patients With Hepatocellular Carcinoma: A Biomarker that is Bruised but Not Broken.
Jearth V; Patil PS; Mehta S; Sundaram S; Seth V; Goel M; Patkar S; Bal M; Rao V
J Clin Exp Hepatol; 2022; 12(3):841-852. PubMed ID: 35677513
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of Hepatocellular Carcinoma Aggressiveness Factors in Turkish Patients.
Akkiz H; Carr BI; Yalçın K K; Guerra V; Kuran S; Altıntaş E; Üsküdar O; Karaoğullarından Ü; Özakyol A; Tokmak S; Yücesoy M; Bahçeci Hİ; Ülkü A; Akçam T; Yalçın Polat K; Ekinci N; Şimşek H; Örmeci N; Sonsuz A; Demir M; Kılıç M; Uygun A; Ballı T; Demir A; Arslan B; Doran F
Oncology; 2018; 94(2):116-124. PubMed ID: 29207378
[TBL] [Abstract][Full Text] [Related]
9. HCC with low- and normal-serum alpha-fetoprotein levels.
Carr BI; Akkiz H; Üsküdar O; Yalçın K; Guerra V; Kuran S; Karaoğullarından Ü; Altıntaş E; Özakyol A; Tokmak S; Ballı T; Yücesoy M; Bahçeci Hİ; Ülkü A; Akçam T; Polat KY; Ekinci N; Şimşek H; Örmeci N; Sonsuz A; Demir M; Kılıç M; Uygun A; Demir A; Delik A; Arslan B; Doran F; Yilmaz S; Tokat Y
Clin Pract (Lond); 2018; 15(1):453-464. PubMed ID: 29576865
[TBL] [Abstract][Full Text] [Related]
10. Identification of Clinical Phenotypes and Related Survival in Patients with Large HCCs.
Carr BI; Guerra V; Donghia R; Farinati F; Giannini EG; Muratori L; Rapaccini GL; Di Marco M; Caturelli E; Zoli M; Sacco R; Celsa C; Campani C; Mega A; Guarino M; Gasbarrini A; Svegliati-Baroni G; Foschi FG; Biasini E; Masotto A; Nardone G; Raimondo G; Azzaroli F; Vidili G; Brunetto MR; Trevisani F
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33546234
[TBL] [Abstract][Full Text] [Related]
11. Serum levels of gamma-glutamyl transpeptidase in relation to HCC human biology and prognosis.
Carr BI; Akkiz H; Bag HG; Karaoğullarından U; Yalçın K; Ekin N; Özakyol A; Altıntaş E; Balaban HY; Şimşek H; Uyanıkoğlu A; Balkan A; Kuran S; Üsküdar O; Ülger Y; Güney B; Delik A
J Transl Sci; 2021 Jun; 7(3):. PubMed ID: 34540270
[TBL] [Abstract][Full Text] [Related]
12. Alpha-fetoprotein and albumin inversely relate to each other and to tumor parameters in patients with hepatocellular carcinoma.
Carr B; Guerra V; Ince V; Isik B; Yilmaz S
Hepatol Forum; 2024; 5(1):11-17. PubMed ID: 38283277
[TBL] [Abstract][Full Text] [Related]
13.
Abouchaleh N; Gabr A; Ali R; Al Asadi A; Mora RA; Kallini JR; Mouli S; Riaz A; Lewandowski RJ; Salem R
J Nucl Med; 2018 Jul; 59(7):1042-1048. PubMed ID: 29217739
[TBL] [Abstract][Full Text] [Related]
14. Tumor multifocality and serum albumin levels can identify groups of patients with hepatocellular carcinoma and portal vein thrombosis having distinct survival outcomes.
Carr BI; Guerra V; Donghia R; Yilmaz S
Ann Med Surg (Lond); 2021 Jun; 66():102458. PubMed ID: 34141428
[TBL] [Abstract][Full Text] [Related]
15. Peripheral blood platelet counts identify prognostically diverse clinical phenotypes in hepatocellular carcinoma.
Carr BI; Bag HG; Yilmaz S
Ann Gastroenterol Dig Syst; 2024; 7(1):. PubMed ID: 38887309
[TBL] [Abstract][Full Text] [Related]
16. Microscopic vascular invasion by hepatocellular carcinoma in liver transplant patients.
Carr BI; Ince V; Bag HG; Ersan V; Usta S; Yilmaz S
Clin Pract (Lond); 2020; 17(3):1497-1505. PubMed ID: 33343877
[TBL] [Abstract][Full Text] [Related]
17. The Combination of Age, International Standardized Ratio, Albumin and γ-Glutamyl Transpeptidase (AIAG), Tumor Size and Alpha Fetoprotein (AFP) Stage as the Prognostic Model for Hepatitis B-Related Hepatocellular Carcinoma.
Liu S; Xu Z; Fang Z; Zhang D; Qin Z; Fan L; Duan J; Yin H; Zhang Y; Pang Q; Tan Y
Int J Gen Med; 2021; 14():4291-4301. PubMed ID: 34408472
[TBL] [Abstract][Full Text] [Related]
18. Low alpha-fetoprotein HCC and the role of GGTP.
Carr BI; Guerra V; Giannini EG; Farinati F; Ciccarese F; Rapaccini GL; Di Marco M; Benvegnù L; Zoli M; Borzio F; Caturelli E; Chiaramonte M; Trevisani F
Int J Biol Markers; 2014 Dec; 29(4):e395-402. PubMed ID: 24832180
[TBL] [Abstract][Full Text] [Related]
19. Significance of platelet and AFP levels and liver function parameters for HCC size and survival.
Carr BI; Guerra V; Giannini EG; Farinati F; Ciccarese F; Rapaccini GL; Di Marco M; Benvegnù L; Zoli M; Borzio F; Caturelli E; Chiaramonte M; Trevisani F;
Int J Biol Markers; 2014 Sep; 29(3):e215-23. PubMed ID: 24526315
[TBL] [Abstract][Full Text] [Related]
20. Association of abnormal plasma bilirubin with aggressive hepatocellular carcinoma phenotype.
Carr BI; Guerra V; Giannini EG; Farinati F; Ciccarese F; Ludovico Rapaccini G; Di Marco M; Benvegnù L; Zoli M; Borzio F; Caturelli E; Chiaramonte M; Trevisani F;
Semin Oncol; 2014 Apr; 41(2):252-8. PubMed ID: 24787296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
